Sparsh Strategic Consulting helps pharmaceutical, biotech, and medtech organisations achieve compliance, quality, and regulatory readiness — backed by 25+ years of global experience.
End-to-end GxP QA consulting, auditing, training, and strategic advisory for life sciences organisations worldwide.
Investigator site, pharmacovigilance, CSV, GDP, and for-cause audits with actionable reports and CAPA management.
Mock inspections, readiness assessments, and post-inspection response for FDA, EMA, MHRA, PMDA, NMPA, MFDS, and TFDA.
GCP, GVP, GLP, GMP, CSV, GDP — QMS development, optimisation, and vendor qualification across all GxP areas.
Risk management across the clinical development cycle, QMS optimisation, and management of serious non-compliance cases.
Customised GCP training, inspection readiness, data integrity programmes, and CAPA implementation workshops.
SaMD, digital health, and wearables quality integration. End-to-end clinical development strategy with holistic patient care perspective.
Tailored solutions across the life sciences spectrum — from multinational pharma to academic research institutions.
Founded on decades of real-world GxP experience — not theory. Every engagement is led by a principal with direct regulatory and audit experience.
Ready to elevate your GxP compliance posture? Drop us a message and a Sparsh principal will respond within 24 hours.